The federal prosecutor has argued that the former export manager of pharmaceutical ingredient producer Alkaloids of Australia should serve prison time after pleading guilty to cartel conduct over the supply of a key chemical in generic stomach cramp drugs.
Facebook owner Meta has filed a bid to pause a case by the consumer regulator over scam cryptocurrency advertisements until the determination of a private criminal action brought by mining magnate Andrew Forrest.
Noni B owner Mosaic Brands has paid $266,400 in fines after allegedly misleading customers about selling “FDA approved” face masks and “ACCC approved” hot water bottles.
Mineralogy has secured unconditional court approval to drop one of the “battle fronts” in its war with CITIC units Sino Iron and Korean Steel, with a judge refusing to impose a “price” on the discontinuance in the form of an undertaking not to revive the claims.
Lighthouse Corporation was holding “a gun to the head” of the court in seeking to adjourn a $480,000 bid for security in a dispute with East Timor over $328 million in alleged losses from a failed fuel supply agreement, a judge has said.
Animal-free dairy and protein company Perfect Day is trying again to patent a composition that it says makes superior vegan cheese and butter, after New Zealand dairy company Fonterra succeeded in opposing its bid to patent the invention.
The only female partner at global technology research firm Information Services Group has sued her employer for alleged sex discrimination and harassment, saying the company is a “hostile environment” for senior women employees.
A judge has ordered two Sydney roof tiling businesses and their directors to pay a total of $420,000 in penalties after making admissions in proceedings brought by the Australian Competition and Consumer Commission alleging they rigged bids for construction at the University of Sydney.
Nine Network has apologised to former member for Bowman, Andrew Laming, over a news segment that accused him of taking a lewd photograph, having struck a confidential settlement after the broadcaster dropped all defences to the politician’s defamation case.
German biotech Fresenius Kabi has struck back at Samsung Bioepis’s latest attack on the validity of its patents for a liquid formulation of top selling immunosuppressant drug Humira, accusing the Korean company of causing its sales to flag by infringing the patent.